Inhibition of locomotion of cancer cells in vivo by anticoagulant therapy. I. Effects of sodium warfarin on V2 cancer cells, granulocytes, lymphocytes and macrophages in rabbits.
D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use; D003585:Cell Biology; D002465:Cell Movement / Q000187:drug effects; D006801:Humans; D007962:Leukocytes / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects; D008264:Macrophages / Q000187:drug effects; D009362:Neoplasm Metastasis / Q000517:prevention & control*; D009369:Neoplasms / Q000150:complications; D009374:Neoplasms, Experimental; D009360:Neoplastic Cells, Circulating; D011517:Prothrombin Time; D011817:Rabbits; D013927:Thrombosis / Q000150:complications; D014859:Warfarin / Q000494:pharmacology*
D000925:Anticoagulants; D014859:Warfarin